Sökning: L773:2153 7658 OR L773:2153 7933
> Arheden Håkan >
Therapeutic Hypothe...
Therapeutic Hypothermia for the Treatment of Acute Myocardial Infarction-Combined Analysis of the RAPID MI-ICE and the CHILL-MI Trials
-
- Erlinge, David (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Cardiol, Clin Sci, S-22185 Lund, Sweden.
-
- Götberg, Matthias (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Cardiol, Clin Sci, S-22185 Lund, Sweden.
-
- Noc, Marko (författare)
- Ctr Intens Internal Med, Ljubljana, Slovenia.
-
visa fler...
-
- Lang, Irene (författare)
- Med Univ Vienna, Dept Cardiol, Vienna, Austria.;Med Univ Vienna, Dept Emergency Med, Vienna, Austria.
-
- Holzer, Michael (författare)
- Med Univ Vienna, Dept Cardiol, Vienna, Austria.;Med Univ Vienna, Dept Emergency Med, Vienna, Austria.
-
- Clemmensen, Peter (författare)
- Nykoebing F Hosp, Dept Cardiol, Nykoebing F, Denmark.
-
- Jensen, Ulf (författare)
- Karolinska Univ Hosp, Dept Med, Cardiol Unit, Stockholm, Sweden.
-
- Metzler, Bernhard (författare)
- Univ Hosp Internal Med, Dept Cardiol, Innsbruck, Austria.
-
- James, Stefan K. (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi
-
- Botker, Hans Erik (författare)
- Aarhus Univ Hosp Skejby, Dept Cardiol, Aarhus, Denmark.
-
- Omerovic, Elmir, 1968 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
- Koul, Sasha (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Cardiol, Clin Sci, S-22185 Lund, Sweden.
-
- Engblom, Henrik (författare)
- Lund University,Lunds universitet,Klinisk fysiologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Physiology (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Clin Psychol, S-22185 Lund, Sweden.
-
- Carlsson, Marcus (författare)
- Lund University,Lunds universitet,Klinisk fysiologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Physiology (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Clin Psychol, S-22185 Lund, Sweden.
-
- Arheden, Håkan (författare)
- Lund University,Lunds universitet,Klinisk fysiologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Physiology (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Clin Psychol, S-22185 Lund, Sweden.
-
- Östlund, Ollie (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
-
- Wallentin, Lars (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi
-
- Klos, Bradley (författare)
- Philips Healthcare, San Diego, CA USA.
-
- Harnek, Jan (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Cardiol, Clin Sci, S-22185 Lund, Sweden.
-
- Olivecrona, Göran (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Nykoebing F Hosp, Dept Cardiol, Nykoebing F, Denmark.
-
visa färre...
-
(creator_code:org_t)
- Mary Ann Liebert Inc, 2015
- 2015
- Engelska.
-
Ingår i: Therapeutic Hypothermia and Temperature Management. - : Mary Ann Liebert Inc. - 2153-7658 .- 2153-7933. ; 5:2, s. 77-84
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
http://dx.doi.org/10...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- In the randomized rapid intravascular cooling in myocardial infarction as adjunctive to percutaneous coronary intervention (RAPID MI-ICE) and rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction CHILL-MI studies, hypothermia was rapidly induced in conscious patients with ST-elevation myocardial infarction (STEMI) by a combination of cold saline and endovascular cooling. Twenty patients in RAPID MI-ICE and 120 in CHILL-MI with large STEMIs, scheduled for primary percutaneous coronary intervention (PCI) within <6 hours after symptom onset were randomized to hypothermia induced by rapid infusion of 600-2000mL cold saline combined with endovascular cooling or standard of care. Hypothermia was initiated before PCI and continued for 1-3 hours after reperfusion aiming at a target temperature of 33 degrees C. The primary endpoint was myocardial infarct size (IS) as a percentage of myocardium at risk (IS/MaR) assessed by cardiac magnetic resonance imaging at 4 +/- 2 days. Patients randomized to hypothermia treatment achieved a mean core body temperature of 34.7 degrees C before reperfusion. Although significance was not achieved in CHILL-MI, in the pooled analysis IS/MaR was reduced in the hypothermia group, relative reduction (RR) 15% (40.5, 28.0-57.6 vs. 46.6, 36.8-63.8, p=0.046, median, interquartile range [IQR]). IS/MaR was predominantly reduced in early anterior STEMI (0-4h) in the hypothermia group, RR=31% (40.5, 28.8-51.9 vs. 59.0, 45.0-67.8, p=0.01, median, IQR). There was no mortality in either group. The incidence of heart failure was reduced in the hypothermia group (2 vs. 11, p=0.009). Patients with large MaR (>30% of the left ventricle) exhibited significantly reduced IS/MaR in the hypothermia group (40.5, 27.0-57.6 vs. 55.1, 41.1-64.4, median, IQR; hypothermia n=42 vs. control n=37, p=0.03), while patients with MaR<30% did not show effect of hypothermia (35.8, 28.3-57.5 vs. 38.4, 27.4-59.7, median, IQR; hypothermia n=15 vs. control n=19, p=0.50). The prespecified pooled analysis of RAPID MI-ICE and CHILL-MI indicates a reduction of myocardial IS and reduction in heart failure by 1-3 hours with endovascular cooling in association with primary PCI of acute STEMI predominantly in patients with large area of myocardium at risk. (ClinicalTrials.gov id NCT00417638 and NCT01379261).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Erlinge, David
-
Götberg, Matthia ...
-
Noc, Marko
-
Lang, Irene
-
Holzer, Michael
-
Clemmensen, Pete ...
-
visa fler...
-
Jensen, Ulf
-
Metzler, Bernhar ...
-
James, Stefan K.
-
Botker, Hans Eri ...
-
Omerovic, Elmir, ...
-
Koul, Sasha
-
Engblom, Henrik
-
Carlsson, Marcus
-
Arheden, Håkan
-
Östlund, Ollie
-
Wallentin, Lars
-
Klos, Bradley
-
Harnek, Jan
-
Olivecrona, Göra ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Therapeutic Hypo ...
- Av lärosätet
-
Uppsala universitet
-
Lunds universitet
-
Göteborgs universitet